Skip to content

Influence of Pain on Exercise-induced Hypoalgesia

The Influence of Pain on Exercise-Induced Hypoalgesia in Healthy Subjects: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04354948
Enrollment
35
Registered
2020-04-21
Start date
2020-06-19
Completion date
2020-09-14
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Exercise-induced hypoalgesia, Pressure pain threshold, hypertonic saline

Brief summary

The purpose of this study is to investigate how acute pain induced by hypertonic saline prior to exercise influence the magnitude of exercise-induced hypoalgesia after a 3 min isometric wallsquat exercise in healthy subjects. The study is a single blinded (investigator) randomized cross-over trial The results from the study may be of great importance to the understanding of exercise-induced hypoalgesia, and whether the presence of pain affects the effects of exercise.

Detailed description

Exercise is recommended to promote and maintain health and as treatment for more than 25 chronic diseases and pain conditions. The mechanisms underlying pain relief of exercise are largely unknown but may be related to the modulation of central descending pain inhibitory pathways after acute exercise bouts. Exercise-induced hypoalgesia (EIH) is typically assessed as the temporary change in PPTs after a short acute exercise bout and EIH is seen as a proxy of descending pain inhibitory control. In general, EIH seems hypoalgesic (functional) in asymptomatic subjects. A hyperalgesic (impaired) EIH response has been reported in different chronic pain populations, although a functional EIH response also has been reported in subgroups of knee osteoarthritis patients. This implies differences in the acute response to exercise between healthy (pain-free) subjects and chronic pain patients, but it is still unknown whether the presence of pain itself affects the pain alleviating response (i.e. the EIH response) to acute exercise. It is hypothesized that acute pain will decrease the EIH response magnitude following hypertonic saline injection compared with the control injection. This study will increase the insight into the EIH mechanisms in healthy subjects in general, and how the presence of pain affects the body's own ability to modulate pain during exercise.

Interventions

A bolus injection (1 ml) of hypertonic saline (5.8%) is injected into the right quadriceps femoris of the quadriceps femoris muscle 1 minute before performance of the 3 min wall squat exercise

BEHAVIORALNo pain (Hypotonic saline)

A bolus injection (1 ml) of isotonic saline (0.9%) is injected into the right quadriceps femoris of the quadriceps femoris muscle 1 minute before performance of the 3 min wall squat exercise

Sponsors

Aalborg University
CollaboratorOTHER
Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Masking description

The researcher responsible for the statistical analyses are blinded to arm allocation.

Intervention model description

This study is a 2-arm randomized controlled cross-over trial with 1 week between arms

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Pain-free * Understands and writes Danish

Exclusion criteria

* Pregnancy * Previous addictive behavior defined as abuse of hash, opioids or other euphoric substances. * Previous painful or mental illnesses, neurological or circulatory diseases in the form of heart or lung disease. * Surgery within last 3 months * Pain on the days of testing * Pain for more than 2 weeks within the last 3 months

Design outcomes

Primary

MeasureTime frameDescription
Pressure pain threshold at the right quadriceps muscle where injection is performed.Before and after the 3 minutes wall squatBetween group comparison of the primary outcome, which is change in pressure pain threshold at the right quadriceps muscle from before wall squat to after wall squat. Pressure pain threshold is measured with a hand held pressure algometer.

Secondary

MeasureTime frameDescription
Pressure pain threshold at the non-dominant trapezius muscleBefore and after the 3 minutes wall squatBetween group comparison of the secondary outcome, which is change in pressure pain threshold at the left trapezius muscle from before wall squat to after wall squat. Pressure pain threshold is measured with a hand held pressure algometer.
Pressure pain threshold at the left quadriceps muscle where injection is not performed.Before and after the 3 minutes wall squatBetween group comparison of the secondary outcome, which is change in pressure pain threshold at the left quadriceps muscle from before wall squat to after wall squat. Pressure pain threshold is measured with a hand held pressure algometer.
Pain Intensity in thighsAssessed before and immediately after hypertonic and isotonic saline injection as well as after 1, 2 and 3 min of wall squat, and immediately after the end of wall squatPain intensity in both thighs are assessed with numerical rating scales with 0 = no pain and 10 = maximal pain.

Other

MeasureTime frameDescription
Pressure pain thresholdAt baseline on both days before saline injectionsCuff pressure pain threshold (cPPT) is assessed using a computer-controlled cuff pressure algometer (CPAR, NociTech, Denmark,). A 13-cm wide silicone tourniquet cuff is wrapped around the right lower leg with an 8-cm distance to the tibial tuberosity. The cuff pressure is increased with a rate of 1 kPa/s and the maximal pressure limit is 100 kPa. The participants use an electronic visual analog scale (VAS) to rate the pressure-induced pain intensity and a button to release the pressure. Zero- and 10-cm extremes on the VAS were defined as no pain and as maximal pain, respectively. The participants are instructed to rate the pain intensity continuously on the electronic VAS from when the pressure was defined as first sensation of pain and to press the pressure release button when the pain was intolerable. The pressure value when the subject rated the sensation of pain as 1 cm on the VAS was defined as the cPPT.
Pressure pain toleranceAt baseline on both days before saline injectionsCuff pressure pain tolerance (cPTT) is assessed using a computer-controlled cuff pressure algometer (CPAR, NociTech, Denmark,). A 13-cm wide silicone tourniquet cuff is wrapped around the right lower leg with an 8-cm distance to the tibial tuberosity. The cuff pressure is increased with a rate of 1 kPa/s and the maximal pressure limit is 100 kPa. The participants use an electronic visual analog scale (VAS) to rate the pressure-induced pain intensity and a button to release the pressure. Zero- and 10-cm extremes on the VAS were defined as no pain and as maximal pain, respectively. The participants are instructed to rate the pain intensity continuously on the electronic VAS from when the pressure was defined as first sensation of pain and to press the pressure release button when the pain was intolerable. The pressure value when the subject terminates the pressure inflation is defined as the cPTT.
Temporal summation of painAt baseline on both days before saline injectionsTemporal summation of pain (TSP) is assessed at the right lower leg with computer-controlled cuff algometry. Ten repeated cuff pressure stimulations lasting 1 second each (1 sec breaks in between) are induced to assess TSP. Stimulations are delivered by rapid inflation of the cuff with an intensity equivalent to the pressure pain tolerance. Subjects rate the pain intensity on an electronic VAS continuously during the sequential stimulation without returning the VAS to zero between stimulations. VAS scores immediately after each stimulus are extracted, and TSP is calculated as the ratio of the last 3 stimulations to the first four stimulations, with positive values indicating an increase in pain intensity ratings during the repeated stimulation.
International Physical Activity Questionnaire (IPAQ)Baseline of first sessionThe IPAQ is suitable for adults between 15 and 69 years of age and is used for sample surveillance of physical activity levels.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026